
With Tendrium for manufacturers and Public Health Intelligence for institutions, you move from fragmented national portals to one operational view — then execute registration, distribution, and tenders with local partners.
Market
EntryMade Clear
Pharmaceutical market intelligence and market entry for Central America. We turn public procurement, pricing, and demand data into ranked opportunities.

With Tendrium for manufacturers and Public Health Intelligence for institutions, you move from fragmented national portals to one operational view — then execute registration, distribution, and tenders with local partners.
Up to
60M+
data points

Central America
Regional roadmap 2026
From Costa Rica live coverage to a published regional roadmap, LifeHub helps you identify high-value opportunities and execute market entry across Central America.
We turn public procurement, pricing and demand data into ranked market opportunities — then support manufacturers from research and regulatory approval to local setup, distribution and tender execution.
Tender, pricing, competitor and demand analysis by molecule — from official public sources.
Registration strategy, MAH/local representation, and compliance across Central America.
Prequalification, pricing, bid support, award follow-through, and local commercial partners.
Warehousing, cold chain, and distribution partners across the region.
Market Volume
Central America and the Dominican Republic form a multi-billion-dollar pharmaceutical bloc. Pharmacy sales and HS 30 imports are separate lenses on scale: one is retail-channel volume, the other is a partial trade basket that includes hospital, industrial, and re-export flows.
Pharmacy volume
US$4.85B
Mar 2024 · +6.6% YoY
HS 30 pharma imports
US$6.02B
SE-COMISCA medicines basket — not retail sales
Audited total market
US$6.02B
CADR retail + non-retail (~USD$6.02B)
India share of HS 30
7.0%
US$419.5M of the USD$6.02B import basket
Pharmacy sales are a retail reference and are not added to imports. Costa Rica’s HS 30 figure exceeds pharmacy sales because of hospital, industrial, and re-export flows.
India HS 30 is importer-reported value as a share of the SE-COMISCA medicines basket. China HS 30 is reported where a Comtrade figure exists; pale bars are 2023 top-10 ceilings. China HS 9018 is the medical-instruments share.
Weighted China share is 11.2% (US$149.9M of US$1.34B). Dominican Republic leads at 30.1%; Costa Rica is only 4.2% despite the largest instrument import bill.
Values in US$ millions except percentages. India and China HS 30 shares use importer-reported Comtrade; volume columns use the regional briefing table.
| Country | Pharmacy | YoY | HS 30 | India HS 30 | China HS 30 | HS 9018 | China HS 9018 |
|---|---|---|---|---|---|---|---|
| Dominican RepublicPROMESE/CAL and SNS | US$1.14B | -2.0% | US$1.01B | US$102.0M | Below top 10 | US$114.3M | US$34.4M |
| GuatemalaMSPAS and IGSS | US$968M | +9.3% | US$1.12B | US$115.0M | US$27.0M | US$122.0M | US$29.4M |
| Costa RicaCCSS | US$731M | +16.3% | US$1.11B | US$31.0M | US$21.8M | US$779.7M | US$32.7M |
| HondurasSESAL and IHSS | US$665M | +9.3% | US$757.0M | US$43.0M | Below top 10 | US$40.3M | US$11.2M |
| El SalvadorMINSAL and ISSS | US$496M | +7.1% | US$646.5M | US$39.0M | Below top 10 | US$76.4M | US$18.5M |
| PanamaMINSA and CSS | US$486M | +3.4% | US$824.3M | US$22.5M | Below top 10 | US$138.6M | US$11.6M |
| NicaraguaMINSA | US$358M | +9.6% | US$550.7M | US$67.0M | US$23.3M | US$66.4M | US$12.4M |
| SE-COMISCA | US$4.85B | +6.6% | US$6.02B | US$419.5M | Reported in GT, CR, NI | US$1.34B | US$149.9M · 11.2% |
Belize is a COMISCA member but is omitted from the source import table. HS 30 and HS 9018 are partial baskets. Gross imports are not accessible demand for any single origin. Sources: SE-COMISCA import briefing, UN Comtrade HS 30.
Our Products
60M+
Regional data points
Full coverage of Central American markets.
Commercial and tender intelligence for manufacturers and distributors entering or growing in Central America.
See Tendrium
Procurement oversight for ministries and public health institutions — Costa Rica live, with a published regional roadmap.
See Public Health Intelligence
Public institutions, professional bodies, and industry partners we work with across the region.
















Tell us about your project. We respond within 48 hours.